(VIANEWS) - Marcus & Millichap (MMI), Antares Pharma (ATRS), Ares Commercial Real Estate Corporation (ACRE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Marcus & Millichap (MMI)
26.8% sales growth and 18.05% return on equity
Marcus & Millichap, Inc., a brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada.
Marcus & Millichap's sales growth this year is expected to be 41.7% and 3.1% for next year.
Year-on-year quarterly revenue growth grew by 109.6%, now sitting on 1.05B for the twelve trailing months.
Volume
Today's last reported volume for Marcus & Millichap is 102484 which is 3.01% above its average volume of 99480.
Marcus & Millichap's sales growth for the next quarter is 26.8%. The company's growth estimates for the present quarter and the next is 33.9% and 10.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.05%.
Volatility
Marcus & Millichap's last day, last week, and last month's current intraday variation average was 0.22%, 1.19%, and 1.16%, respectively.
Marcus & Millichap's highest amplitude of average volatility was 3.84% (day), 3.70% (last week), and 2.91% (last month), respectively.
Marcus & Millichap's Stock Yearly Top and Bottom Value
Marcus & Millichap's stock is valued at $46.48 at 15:22 EST, way below its 52-week high of $52.25 and way higher than its 52-week low of $32.67.
Marcus & Millichap's Moving Average
Marcus & Millichap's value is under its 50-day moving average of $47.93 and way higher than its 200-day moving average of $41.65.2. Antares Pharma (ATRS)
17.4% sales growth and 63.08% return on equity
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas.
Antares Pharma's sales growth this year is expected to be 22.1% and 23.2% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 179.38M for the twelve trailing months.
Volume
Today's last reported volume for Antares Pharma is 796905 which is 17.12% above its average volume of 680414.
Antares Pharma's sales growth for the next quarter is 17.4%. The company's growth estimates for the ongoing quarter and the next is a negative 66.7% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.08%.
Volatility
Antares Pharma's last day, last week, and last month's current intraday variation average was 2.45%, 1.95%, and 1.27%, respectively.
Antares Pharma's highest amplitude of average volatility was 3.36% (day), 3.25% (last week), and 2.86% (last month), respectively.
Antares Pharma's Stock Yearly Top and Bottom Value
Antares Pharma's stock is valued at $3.27 at 15:22 EST, way under its 52-week high of $5.07 and above its 52-week low of $3.11.
Antares Pharma's Moving Average
Antares Pharma's value is under its 50-day moving average of $3.42 and way below its 200-day moving average of $3.83.3. Ares Commercial Real Estate Corporation (ACRE)
16.1% sales growth and 10.11% return on equity
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States.
Ares Commercial Real Estate Corporation's sales growth this year is expected to be 18% and 11.4% for next year.
Year-on-year quarterly revenue growth declined by 11.2%, now sitting on 94.13M for the twelve trailing months.
Volume
Today's last reported volume for Ares Commercial Real Estate Corporation is 337566 which is 25.88% below its average volume of 455460.
Ares Commercial Real Estate Corporation's sales growth for the next quarter is 16.1%. The company's growth estimates for the present quarter and the next is a negative 9.8% and negative -10%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.11%.
Volatility
Ares Commercial Real Estate Corporation's last day, last week, and last month's current intraday variation average was 0.87%, 0.39%, and 0.96%, respectively.
Ares Commercial Real Estate Corporation's highest amplitude of average volatility was 1.35% (day), 1.32% (last week), and 1.88% (last month), respectively.
Ares Commercial Real Estate Corporation's Stock Yearly Top and Bottom Value
Ares Commercial Real Estate Corporation's stock is valued at $14.89 at 15:22 EST, way below its 52-week high of $16.98 and way higher than its 52-week low of $11.16.
Ares Commercial Real Estate Corporation's Moving Average
Ares Commercial Real Estate Corporation's worth is under its 50-day moving average of $15.01 and below its 200-day moving average of $15.13.4. Ball Corporation (BLL)
13.7% sales growth and 26.61% return on equity
Ball Corporation supplies aluminum packaging products to the beverage, personal care, automotive, paint, healthcare, and household products industries.
Ball Corporation's sales growth this year is anticipated to be 15.6% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 12.78B for the twelve trailing months.
Volume
Today's last reported volume for Ball Corporation is 2762290 which is 49.94% above its average volume of 1842230.
Ball Corporation's sales growth for the next quarter is 13.7%. The company's growth estimates for the current quarter and the next is 12.4% and 22.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.61%.
Volatility
Ball Corporation's last day, last week, and last month's current intraday variation average was 0.52%, 3.68%, and 1.86%, respectively.
Ball Corporation's highest amplitude of average volatility was 3.27% (day), 3.85% (last week), and 2.98% (last month), respectively.
Ball Corporation's Stock Yearly Top and Bottom Value
Ball Corporation's stock is valued at $93.50 at 15:22 EST, below its 52-week high of $98.09 and way higher than its 52-week low of $77.95.
Ball Corporation's Moving Average
Ball Corporation's value is higher than its 50-day moving average of $92.41 and higher than its 200-day moving average of $88.47.Previous days news about Ball Corporation(BLL)
- According to Benzinga on Thursday, 27 January, "Ball Metalpack was a joint venture owned by Platinum Equity and Ball Corporation (NYSE:BLL)."
5. Dominion Resources (D)
12.8% sales growth and 7.53% return on equity
Dominion Energy, Inc. produces and transports energy.
Dominion Resources's sales growth this year is anticipated to be 5.3% and 8.6% for next year.
Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 14.04B for the twelve trailing months.
Volume
Today's last reported volume for Dominion Resources is 2594880 which is 20.57% below its average volume of 3267040.
Dominion Resources's sales growth is a negative 0% for the current quarter and 12.8% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 2.8% and 19.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.53%.
Volatility
Dominion Resources's last day, last week, and last month's current intraday variation average was 1.60%, 0.99%, and 0.66%, respectively.
Dominion Resources's highest amplitude of average volatility was 2.71% (day), 2.44% (last week), and 1.86% (last month), respectively.
Dominion Resources's Stock Yearly Top and Bottom Value
Dominion Resources's stock is valued at $79.46 at 15:22 EST, below its 52-week high of $86.23 and way higher than its 52-week low of $67.85.
Dominion Resources's Moving Average
Dominion Resources's value is above its 50-day moving average of $74.58 and above its 200-day moving average of $76.19.6. Roper Industries (ROP)
11% sales growth and 10.16% return on equity
Roper Technologies, Inc. designs and develops software, and engineered products and solutions worldwide.
Roper Industries's sales growth this year is anticipated to be 16% and 6.1% for next year.
Year-on-year quarterly revenue growth grew by 21.7%, now sitting on 5.99B for the twelve trailing months.
Volume
Today's last reported volume for Roper Industries is 520774 which is 21.44% above its average volume of 428800.
Roper Industries's sales growth for the next quarter is 11%. The company's growth estimates for the ongoing quarter and the next is 21.5% and 11.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.16%.
Volatility
Roper Industries's last day, last week, and last month's current intraday variation average was 2.83%, 1.50%, and 1.06%, respectively.
Roper Industries's highest amplitude of average volatility was 4.19% (day), 3.55% (last week), and 2.80% (last month), respectively.
Roper Industries's Stock Yearly Top and Bottom Value
Roper Industries's stock is valued at $435.47 at 15:22 EST, way under its 52-week high of $505.00 and way above its 52-week low of $365.23.
Roper Industries's Moving Average
Roper Industries's worth is under its 50-day moving average of $469.05 and below its 200-day moving average of $467.40.7. Proto Labs (PRLB)
8.4% sales growth and 4.28% return on equity
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.
Proto Labs's sales growth this year is anticipated to be 10.9% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 469.72M for the twelve trailing months.
Volume
Today's last reported volume for Proto Labs is 549672 which is 14.25% above its average volume of 481072.
Proto Labs's sales growth for the next quarter is 8.4%. The company's growth estimates for the present quarter and the next is a negative 46% and negative -5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.28%.
Volatility
Proto Labs's last day, last week, and last month's current intraday variation average was 2.03%, 0.89%, and 1.72%, respectively.
Proto Labs's highest amplitude of average volatility was 4.51% (day), 3.54% (last week), and 4.17% (last month), respectively.
Proto Labs's Stock Yearly Top and Bottom Value
Proto Labs's stock is valued at $49.35 at 15:22 EST, way below its 52-week high of $286.57 and above its 52-week low of $47.57.
Proto Labs's Moving Average
Proto Labs's value is below its 50-day moving average of $52.25 and way under its 200-day moving average of $75.57.8. Akamai Technologies (AKAM)
5.7% sales growth and 13.94% return on equity
Akamai Technologies, Inc. provides cloud services for delivering, optimizing, and securing content and business applications over the Internet in the United States and internationally.
Akamai Technologies's sales growth this year is expected to be 7.6% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 3.33B for the twelve trailing months.
Volume
Today's last reported volume for Akamai Technologies is 984826 which is 28.95% below its average volume of 1386180.
Akamai Technologies's sales growth for the next quarter is 5.7%. The company's growth estimates for the ongoing quarter and the next is 6.1% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.94%.
Volatility
Akamai Technologies's last day, last week, and last month's current intraday variation average was 1.80%, 1.45%, and 0.95%, respectively.
Akamai Technologies's highest amplitude of average volatility was 3.29% (day), 3.03% (last week), and 2.20% (last month), respectively.
Akamai Technologies's Stock Yearly Top and Bottom Value
Akamai Technologies's stock is valued at $112.17 at 15:22 EST, way under its 52-week high of $124.91 and way higher than its 52-week low of $92.64.